Untreated
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Lenalidomide in Combination With R-DA-EPOCH in Patients With Untreated DLBCL With MYC Rearrangement (NCT04432714) | The First Affiliated Hospital with Nanjing Medical University | 2020-06-09 |
| Sequential Chemotherapy and Lenalidomide Followed by Rituximab and Lenalidomide Maintenance for Untreated Mantle Cell Lymphoma (NCT02633137) | Memorial Sloan Kettering Cancer Center | 2015-12-14 |
| Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL) (NCT00628238) | Chronic Lymphocytic Leukemia Research Consortium | 2008-02-01 |
Track Untreated automatically
Every clearance here is in the API, with alerts when new ones post.